Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardiff Oncology (CRDF) FCF Margin (2016 - 2025)

Cardiff Oncology (CRDF) has disclosed FCF Margin for 15 consecutive years, with 2743.62% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 400274.0% to 2743.62% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6520.57% through Dec 2025, down 100990.0% year-over-year, with the annual reading at 6520.57% for FY2025, 100183.0% down from the prior year.
  • FCF Margin hit 2743.62% in Q4 2025 for Cardiff Oncology, up from 9043.33% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 2743.62% in Q4 2025 to a low of 14081.08% in Q1 2022.
  • Historically, FCF Margin has averaged 7217.17% across 5 years, with a median of 6466.29% in 2023.
  • Biggest five-year swings in FCF Margin: soared 677814bps in 2024 and later tumbled -875050bps in 2025.
  • Year by year, FCF Margin stood at 5487.22% in 2021, then fell by -24bps to 6789.84% in 2022, then soared by 33bps to 4581.41% in 2023, then plummeted by -47bps to 6746.36% in 2024, then surged by 59bps to 2743.62% in 2025.
  • Business Quant data shows FCF Margin for CRDF at 2743.62% in Q4 2025, 9043.33% in Q3 2025, and 6158.68% in Q2 2025.